Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000404344

Medchemexpress LLC Lm10 | 1316695-35-8 | 99.9% | 229.22 | 50 MG
SDP

Catalog No. 5000404344
Encompass_Preferred

LM10 is a potent inhibitor of tryptophan 2,3-dioxygenase (TDO), an hepatic enzyme that degrades tryptophan along the kynurenine pathway. This compound shows potential for research in cancer diseases. It exhibits good TDO inhibition (Ki = 5.6 μM) with a competitive inhibition profile and does not inhibit IDO. LM10 has high solubility and bioavailability without obvious signs of toxicity.

  • Potent inhibitor of tryptophan 2,3-dioxygenase (TDO).
  • Potential for cancer disease research.
  • Displays good TDO inhibition (Ki = 5.6 μM) with a competitive inhibition profile.
  • Does not inhibit IDO.
  • High solubility and bioavailability.
  • No obvious signs of toxicity.
  • Prevents the growth of TDO-expressing P815 tumor cells in vivo.
  • Promotes better rejection of control clone P815B cl1, which does not express TDO, in vivo.

Catalog No. 50-004-04344 Supplier Medchemexpress LLC Supplier No. HY3329850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

LM10 is a potent inhibitor of tryptophan 2,3-dioxygenase (TDO), an hepatic enzyme that degrades tryptophan along the kynurenine pathway. This compound shows potential for research in cancer diseases. It exhibits good TDO inhibition (Ki = 5.6 μM) with a competitive inhibition profile and does not inhibit IDO. LM10 has high solubility and bioavailability without obvious signs of toxicity.

  • Potent inhibitor of tryptophan 2,3-dioxygenase (TDO).
  • Potential for cancer disease research.
  • Displays good TDO inhibition (Ki = 5.6 μM) with a competitive inhibition profile.
  • Does not inhibit IDO.
  • High solubility and bioavailability.
  • No obvious signs of toxicity.
  • Prevents the growth of TDO-expressing P815 tumor cells in vivo.
  • Promotes better rejection of control clone P815B cl1, which does not express TDO, in vivo.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.